Co-Production of NDM-1 and OXA-10 β-Lactamase in Strain Causing Urinary Tract Infection.

Infect Drug Resist

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.

Published: March 2022

In this study, we describe, for the first time, the co-existence of and in a carbapenem-resistant strain DY2019 isolated from a patient with urinary tract infection in China. We aimed to investigate the genomic context of two β-lactamase-producing plasmids and characterize the transmission mechanism of the carbapenemase-encoding gene. Whole-genome sequencing of strain DY2019 was performed with Nanopore and Illumina platforms, which revealed a chromosome sequence with the length of 4,830,928 bp, an IncC group plasmid pDY2019-OXA (size of 178,134 bp), and a novel IncHI2 group plasmid pDY2019-NDM (length 348,495 bp). A total of 16 antimicrobial resistance genes (ARGs) that confer resistance to nine different antibiotic groups were identified in strain DY2019, and 11 of them were carried by plasmid pDY2019-OXA. These data and analyses suggest that the carbapenem-resistant strains may serve as potential reservoir of carbapenemase and highlight the need for further close surveillance of this species in clinical settings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943965PMC
http://dx.doi.org/10.2147/IDR.S347943DOI Listing

Publication Analysis

Top Keywords

strain dy2019
12
urinary tract
8
tract infection
8
group plasmid
8
plasmid pdy2019-oxa
8
co-production ndm-1
4
ndm-1 oxa-10
4
oxa-10 β-lactamase
4
strain
4
β-lactamase strain
4

Similar Publications

Co-Production of NDM-1 and OXA-10 β-Lactamase in Strain Causing Urinary Tract Infection.

Infect Drug Resist

March 2022

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.

In this study, we describe, for the first time, the co-existence of and in a carbapenem-resistant strain DY2019 isolated from a patient with urinary tract infection in China. We aimed to investigate the genomic context of two β-lactamase-producing plasmids and characterize the transmission mechanism of the carbapenemase-encoding gene. Whole-genome sequencing of strain DY2019 was performed with Nanopore and Illumina platforms, which revealed a chromosome sequence with the length of 4,830,928 bp, an IncC group plasmid pDY2019-OXA (size of 178,134 bp), and a novel IncHI2 group plasmid pDY2019-NDM (length 348,495 bp).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!